


Healthcare News Roundup: Cardiology
HSMN NewsFeed - 11 Aug 2008
Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For KYNAPID(TM)
Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For KYNAPID(TM)
HSMN NewsFeed - 8 Aug 2008
Multaq(R) (dronedarone) Granted FDA Priority Review for Patients with Atrial Fibrillation
Multaq(R) (dronedarone) Granted FDA Priority Review for Patients with Atrial Fibrillation
HSMN NewsFeed - 7 Aug 2008
CardioWest(TM) Artificial Heart Approved For Highest Reimbursement in CMS History
CardioWest(TM) Artificial Heart Approved For Highest Reimbursement in CMS History
HSMN NewsFeed - 6 Aug 2008
First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial
First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial
HSMN NewsFeed - 6 Aug 2008
St. Jude Medical Announces Japanese Approval of the Durata Defibrillation Lead
St. Jude Medical Announces Japanese Approval of the Durata Defibrillation Lead
HSMN NewsFeed - 1 Aug 2008
Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd.
Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd.
HSMN NewsFeed - 31 Jul 2008
Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Simvastatin Tablets
Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Simvastatin Tablets
HSMN NewsFeed - 30 Jul 2008
Medtronic Starts U.S. Arm of Global Study Comparing Safety of Endeavor(R) and Cypher(R) Drug-Eluting Stents
Medtronic Starts U.S. Arm of Global Study Comparing Safety of Endeavor(R) and Cypher(R) Drug-Eluting Stents
HSMN NewsFeed - 28 Jul 2008
OrbusNeich Adds Sapphire(TM) NC Coronary Dilatation Catheter to Product Line-Up
OrbusNeich Adds Sapphire(TM) NC Coronary Dilatation Catheter to Product Line-Up
HSMN NewsFeed - 22 Jul 2008
Response Biomedical Receives US FDA Clearance for RAMP(R) NT-proBNP Test for Diagnosis of Heart Failure
Response Biomedical Receives US FDA Clearance for RAMP(R) NT-proBNP Test for Diagnosis of Heart Failure
HSMN NewsFeed - 21 Jul 2008
Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
HSMN NewsFeed - 11 Jul 2008
Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients
Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients
HSMN NewsFeed - 9 Jul 2008
Terumo Cardiovascular Systems Files Patent Infringement Complaint Against Maquet Affiliates
Terumo Cardiovascular Systems Files Patent Infringement Complaint Against Maquet Affiliates
HSMN NewsFeed - 9 Jul 2008
ATS Medical Confirms Excellent Durability of the ATS Open Pivot Mechanical Heart Valve
ATS Medical Confirms Excellent Durability of the ATS Open Pivot Mechanical Heart Valve
HSMN NewsFeed - 7 Jul 2008
Foothills Medical Centre Adopts Newest Technology for the Removal of Pacemaker Leads
Foothills Medical Centre Adopts Newest Technology for the Removal of Pacemaker Leads
HSMN NewsFeed - 3 Jul 2008
Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer
Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer
HSMN NewsFeed - 30 Jun 2008
Acusphere Announces FDA Acceptance of Imagify(TM) NDA for Detection of Coronary Artery Disease
Acusphere Announces FDA Acceptance of Imagify(TM) NDA for Detection of Coronary Artery Disease
HSMN NewsFeed - 30 Jun 2008
Patient Receives vProtect(TM) Luminal Shield in First-Ever Vulnerable Plaque Clinical Trial
Patient Receives vProtect(TM) Luminal Shield in First-Ever Vulnerable Plaque Clinical Trial
HSMN NewsFeed - 23 Jun 2008
Cambridge Heart Licenses Technology from Massachusetts Institute of Technology
Cambridge Heart Licenses Technology from Massachusetts Institute of Technology
HSMN NewsFeed - 23 Jun 2008
ATS Medical Announces Canadian Regulatory Approval of the ATS Open Pivot AP360 Mechanical Heart Valve
ATS Medical Announces Canadian Regulatory Approval of the ATS Open Pivot AP360 Mechanical Heart Valve
